A prospective, randomized trial to assess a protease inhibitor-based regimen switch strategy to manage integrase inhibitor-related weight gain

被引：0
|
作者：
Short, W. R. [1 ]
Ramgopal, M. [2 ]
Hagins, D. P. [3 ]
Lee, J. [4 ]
Simonson, R. B. [4 ]
Hsu, T. -H. [4 ]
Xu, P. [5 ]
Anderson, D. [4 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[2] Midway Immunol & Res Ctr, Ft Pierce, FL USA
[3] Chatham CARE Ctr, Savannah, GA USA
[4] Janssen Sci Affairs LLC, Titusville, FL USA
[5] Janssen Res & Dev LLC, Titusville, FL USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2023年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OALBB0502
引用
收藏
页数：1
相关论文
共 45 条
  • [21] Reuse of Nevirapine in Exposed HIV-Infected Children After Protease Inhibitor-Based Viral Suppression A Randomized Controlled Trial
    Coovadia, Ashraf
    Abrams, Elaine J.
    Stehlau, Renate
    Meyers, Tammy
    Martens, Leigh
    Sherman, Gayle
    Hunt, Gillian
    Hu, Chih-Chi
    Tsai, Wei-Yann
    Morris, Lynn
    Kuhn, Louise
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (10): : 1082 - 1090
  • [22] Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen:: A randomized trial
    Molina, JM
    Journot, V
    Morand-Joubert, L
    Yéni, P
    Rozenbaum, W
    Rancinan, C
    Fournier, S
    Morlat, P
    Palmer, P
    Dupont, B
    Goujard, C
    Dellamonica, P
    Collin, F
    Poizot-Martin, I
    Chêne, G
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (06): : 830 - 839
  • [23] Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-related fatigue
    Wright, Alexi A.
    Poort, Hanneke
    Tavormina, Anna
    Schmiege, Sarah J.
    Matulonis, Ursula A.
    Campos, Susana M.
    Liu, Joyce F.
    Slivjak, Elizabeth T.
    Gilmour, Anna L.
    Salinger, Julia M.
    Haggerty, Ashley F.
    Arch, Joanna J.
    GYNECOLOGIC ONCOLOGY, 2023, 177 : 165 - 172
  • [24] Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada
    Rebeiro, Peter F.
    Jenkins, Cathy A.
    Bian, Aihua
    Lake, Jordan E.
    Bourgi, Kassem
    Moore, Richard D.
    Horberg, Michael A.
    Matthews, W. Christopher
    Silverberg, Michael J.
    Thorne, Jennifer
    Mayor, Angel M.
    Lima, Viviane D.
    Palella, Frank J.
    Saag, Michael S.
    Althoff, Keri N.
    Gill, M. John
    Wong, Cherise
    Klein, Marina B.
    Crane, Heidi M.
    Marconi, Vincent C.
    Shepherd, Bryan E.
    Sterling, Timothy R.
    Koethe, John R.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2234 - E2242
  • [25] Long-term follow-up after a switch to bictegravir, emtricitabine, tenofovir alafenamide (B/F/TAF) from a boosted protease inhibitor-based regimen
    Rockstroh, J.
    Molina, J. M.
    Post, F.
    Fox, J.
    Koenig, E.
    Daar, E. S.
    Ruane, P.
    Crofoot, G.
    Oguchi, G.
    Creticos, C.
    Liu, A.
    Andreatta, K.
    Graham, H.
    Brainard, D.
    Martin, H.
    HIV MEDICINE, 2021, 22 : 5 - 5
  • [26] Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals
    Moron-Lopez, Sara
    Navarro, Jordi
    Jimenez, Montse
    Rutsaert, Sofie
    Urrea, Victor
    Puertas, Maria C.
    Torrella, Ariadna
    De Clercq, Laura
    Ribas, Bibiana Planes
    Galvez, Cristina
    Salgado, Maria
    Vandekerckhove, Linos
    Blanco, Julia
    Crespo, Manel
    Martinez-Picado, Javier
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (08) : 1320 - 1328
  • [27] Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study
    Ying Cao
    Yang Han
    Jing Xie
    Qu Cui
    Lixia Zhang
    Yijia Li
    Yanling Li
    Xiaojing Song
    Ting Zhu
    Taisheng Li
    BMC Infectious Diseases, 13
  • [28] Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study
    Cao, Ying
    Han, Yang
    Xie, Jing
    Cui, Qu
    Zhang, Lixia
    Li, Yijia
    Li, Yanling
    Song, Xiaojing
    Zhu, Ting
    Li, Taisheng
    BMC INFECTIOUS DISEASES, 2013, 13
  • [29] Switch to dolutegravir from a boosted protease inhibitor associated with significant weight gain over 48 weeks in NEAT-022, a randomised 96-week trial
    Waters, L.
    Assoumou, L.
    Rusconi, S.
    Domingo, P.
    Gompels, M.
    de Wit, S.
    Raffi, F.
    Stephan, C.
    Rockstroh, J.
    Katlama, C.
    Behrens, G.
    Gatell, J.
    Pozniak, A.
    Martinez, E.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [30] Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): A study protocol for a pilot randomized controlled trial
    Siou K.
    Walmsley S.L.
    Murphy K.E.
    Raboud J.
    Loutfy M.
    Yudin M.H.
    Silverman M.
    Ladhani N.N.
    Serghides L.
    Pilot and Feasibility Studies, 2 (1)
12345